kanjinti-powd-for-conc-for-soln-for-infusion-150-mg

Kanjinti powd for conc for soln for infusion 150 mg (150 mg)

Manufacturer: Amgen

Distributor: Zuellig

Contents: trastuzumab

MIMS Class: Targeted Cancer Therapy

Form: Vial

Shape: Undefined

Sign up for Free to Continue Reading

Continue with Google

Sign Up With Email

Already a member? Sign In